Reversible Severe Parkinsonism Caused by Extra-Pontine Myelinolysis in a patient with Primary Adrenal Failure.

dc.contributor.authorVaroglu, Asuman Orhan
dc.contributor.authorAksoy, Asude
dc.contributor.authorAvarisli, Aysenur
dc.contributor.authorDarici, Didem
dc.contributor.authorAkbas, Emre
dc.date.accessioned2025-05-10T19:28:21Z
dc.date.issued2023
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractPURPOSE: Extrapontine myelinolysis (EPM) is a highly uncommon, life-threatening disease, particularly in individuals who initially appear with severe clinical symptoms. Here, we describe a case of EPM caused by the rapid correction of hyponatremia that had severe clinical signs at first but parkinsonism symptoms were fully improved after treatment. CASE REPORT: A 46-year-old female patient was admitted to the hospital due to impaired consciousness. Her medical history reveals that she has PAI, or primary adrenal insufficiency. Initial laboratory measurements showed that the serum's sodium (Na) concentration was 104 mEq/L, chloride (Cl) content was 70 mmol/L, potassium (K) content was 4.95 mEq/L, glucose was 42 mg/dL, hydrogen potential (Ph) was 7.12, and bicarbonate (HCO3) concentration was 10 mmol/l. The adrenocorticotropic hormone (ACTH) level was 21 mg/ml, while the cortisol level was 1.2ug/dl. Her mental state was unclear, she had sluggish hypophonic speech, generalized akinesia/rigidity in both upper and lower extremities, trouble swallowing solid and liquid meals, and sialorrhea were all discovered after the Na level was corrected. Hyperintense lesions were visible in the bilateral putamen and caudate nuclei of the Magnetic Resonance Imaging (MRI) T2 and flair-weighted scans, which indicate EPM. EPM was treated with corticosteroids and dopamine agonists, and she was eventually released after complete recovery. CONCLUSION: Even if there are severe clinical symptoms at first, prompt diagnosis and treatment, such as dopaminergic, corticosteroid, and palliative therapy, can save a patient's life.
dc.identifier.endpage100
dc.identifier.issn0172-780X
dc.identifier.issn2354-4716
dc.identifier.issue2
dc.identifier.pmid37182231
dc.identifier.scopusqualityQ3
dc.identifier.startpage97
dc.identifier.urihttps://hdl.handle.net/20.500.14730/7289
dc.identifier.volume44
dc.identifier.wosWOS:001101641000005
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherMaghira & Maas Publications
dc.relation.ispartofNeuroendocrinology Letters
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250302
dc.subjectAdrenal insufficiency
dc.subjectprimer adrenal insufficiency (PAI)
dc.subjectparkinsonism
dc.subjectAddison's disease
dc.subjectextrapontine myelinolysis
dc.subjectcentral pontine myelinolysis
dc.subjectosmotic demyelination
dc.subjecthyponatremia
dc.subjectMRI
dc.titleReversible Severe Parkinsonism Caused by Extra-Pontine Myelinolysis in a patient with Primary Adrenal Failure.
dc.typeArticle

Dosyalar